Even during the most difficult of times, the life science sector continues to push forward with innovation. The recent rapid progression of drug development, diagnostic tests, and healthcare tools has propelled us into new territory that was unthinkable – or even unknown – just a decade ago. While other sectors beg for bailouts, biopharma has remained buoyant and resilient in the face of COVID-19.
Read our new special report Biopharma and Tech Innovators Summer 2020 to learn more about the cutting-edge companies behind these innovations that are disrupting the sector and revolutionizing the healthcare landscape. Created in partnership with EBD Group.